Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori: Scratch and win

References

• Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175–6.
   PubMed Web of Science ®Google Scholar
• Fischbach W. Primary gastric lymphoma of MALT: considerations of pathogenesis, diagnosis and therapy. Can J Gastroenterol 2000;14 Suppl D: S44–50.
   Google Scholar
• Wotherspoon A, Chott A, Gascoyne RD, Muller Hermelink HK. Lymphoma of the stomach. In: Hamilton SR, Aaltonen LA, editors. Pathology and genetics, tumors of the digestive system. Lyon: IARC Press; 2000. pp 57–61
   Google Scholar
• Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575–7.
   Google Scholar
• Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Stolte M. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection: MALT Lymphoma Study Group. Lancet 1995;345: 1591–4.
   Google Scholar
• Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF, et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 2002;97:292–7.
   PubMed Web of Science ®Google Scholar
• Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, et al. Treatment of low-grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 2001;86:609–17.
   Google Scholar
• Chen LT, Lin JT, Shyu RY, Jan CM, Chen CL, Chiang IP, et al. Prospective study of Helicobacter pylori eradication therapy in stage I (E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001;19:4245–51.
   PubMed Web of Science ®Google Scholar
• Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001;357:39–40.
   PubMed Web of Science ®Google Scholar
• Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiation Oncol Biol Phys 2000;46:1093–103.
   PubMed Web of Science ®Google Scholar
• Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249–59.
   PubMed Web of Science ®Google Scholar
• Wan JH, Trainor KJ, Brisco MJ, Morley AA. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990;43:888–90.
   PubMed Web of Science ®Google Scholar
• Reed TJ, Reid A, Walberg K, O’Leary TJ, Frizzera G. Determination of B-cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction. Diagn Mol Pathol 1993;2:42–9.
   Google Scholar
• Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis 2002;6:335–47.
   PubMedGoogle Scholar
• Rugge M, Busatto G, Cassaro M, Shiao YH, Russo V, Leandro G, et al. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999;85:2506–11.
   PubMedGoogle Scholar
• Spencer J, Finn T, Puldorf KA, Mason DY, Isaacson PG. The human gut contains a novel population of B lymphocytes which resemble marginal zone cells. Clin Exp Immunol 1985;62:607–12.
   Google Scholar
• Thiede C, Wundisch T, Alpen B, Neubauer B, Morgner A, Schmitz M, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B cell lymphoma. J Clin Oncol 2001;19:1600–9.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Aoyagi K, Furuse M, Suekane H, Matsumoto T, Yao T, et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 1998;152:1271–9.
   PubMed Web of Science ®Google Scholar
• Ruskone-Fourmestarux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A, et al. Predictive factors for regression of gastric MALT lymphoma after antiHelicobacter pylori treatment. Gut 2001;48: 297–303.
   Google Scholar
• Eck M, Greiner A, Schmausser B, Eck H, Kolve M, Fischbach W, et al. Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: differences between histologic and serologic diagnosis. Mod Pathol 1999;12:1148–51.
   PubMedGoogle Scholar
• Grillo-Lopez AJ, Dallaire BK, McClure A, Weaver R, Varns C, Wei A, et al. Monoclonal antibodies: a new era in the treatment of non-Hodgkin’s lymphoma. Curr Pharm Biotechnol 2001;2:301–11.
   Google Scholar
• Walewski J, Kraszewska E, Mioduszewska O, Romejko Jarosinska J, Hellmann A, Czyz J, et al. Rituximab (Mabthera, Rituxican) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study. Med Oncol 2001;18:141–8.
   Google Scholar
• Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D, et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998;92:1927–32.
   PubMed Web of Science ®Google Scholar
• Conconi A, Thieblemont C, Martinelli G, Ferreri AJM, Devizzi L, Peccatori F, et al. Activity of rituximab in extranodal marginal zone lymphomas (MALT-Type). The 43rd Annual Meeting of the American Society of Hematology, Orlando, Florida, 7–11 December. Blood 2001;98: 3354.
   Google Scholar
• Conconi A, Martinelli G, Thiéblemont C, Ferreri AJM, Devizzi L, Pe ccatori F, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2002;11:3496–R4.
   Google Scholar
• Kobayashi D, Eishi Y, Ohkusa T, Ishige, Suzuki T, Minami J, et al. Gastric mucosal density of Helicobacter pylori estimated by real-time PCR compared with results of urea breath test and histological grading. J Med Microbiol 2002;51:305–11.
   PubMedGoogle Scholar
• Lin SY, Jeng YS, Wang CK, Ko FT, Lin KY, Wang CS, et al. Polymerase chain reaction diagnosis of Helicobacter pylori in gastroduodenal diseases: comparison with culture and his topathological examinations. J Gastroenterol Hepatol 1996;11:286–9.
   PubMed Web of Science ®Google Scholar
• Luppi M, Longo G, Ferrari MG, Ferrara L, Marasca R, Barozzi P, et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Hematol 1996; 94:373–5.
   PubMed Web of Science ®Google Scholar
• Tkoub EM, Haioun C, Pawlotsky JM, Dhumeaux D, Delchier JC. Chronic hepatitis C virus and gastric MALT lymphoma. Blood 1998;91:360.
   Google Scholar
• Tursi A, Brandimante G, Chiarelli F, Spagnoli A, Torello M. Detection of HCV RNA in gastric mucosa-associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma. Am J Gastroenterol 2002;97:1802–6.
   Google Scholar